These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39274896)

  • 1. Stability Evaluation and Pharmacokinetic Profiling of Vepdegestrant in Rodents Using Liquid Chromatography-Tandem Mass Spectrometry.
    Choi HI; Choi J; Kim JW; Lee YH; Cho KH; Koo TS
    Molecules; 2024 Aug; 29(17):. PubMed ID: 39274896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of LC-MS/MS methods for the pharmacokinetic assessment of the PROTACs bavdeglutamide (ARV-110) and vepdegestrant (ARV-471).
    Niessen J; Nilsson JM; Peters K; Indulkar A; Borchardt T; Koziolek M; Lennernäs H; Dahlgren D; Hedeland M
    J Pharm Biomed Anal; 2024 Oct; 249():116348. PubMed ID: 38996751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an LC-MS/MS Method for ARV-110, a PROTAC Molecule, and Applications to Pharmacokinetic Studies.
    Nguyen TT; Kim JW; Choi HI; Maeng HJ; Koo TS
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs.
    Choi HI; Kim T; Lee SW; Woo Kim J; Ju Noh Y; Kim GY; Jin Park H; Chae YJ; Lee KR; Kim SJ; Koo TS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122862. PubMed ID: 34332199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2- advanced breast cancer.
    Hamilton EP; Ma C; De Laurentiis M; Iwata H; Hurvitz SA; Wander SA; Danso M; Lu DR; Perkins Smith J; Liu Y; Tran L; Anderson S; Campone M
    Future Oncol; 2024; 20(32):2447-2455. PubMed ID: 39072356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models.
    Gough SM; Flanagan JJ; Teh J; Andreoli M; Rousseau E; Pannone M; Bookbinder M; Willard R; Davenport K; Bortolon E; Cadelina G; Gordon D; Pizzano J; Macaluso J; Soto L; Corradi J; Digianantonio K; Drulyte I; Morgan A; Quinn C; Békés M; Ferraro C; Chen X; Wang G; Dong H; Wang J; Langley DR; Houston J; Gedrich R; Taylor IC
    Clin Cancer Res; 2024 Aug; 30(16):3549-3563. PubMed ID: 38819400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of astragaloside III in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study.
    Zhai Y; Li P; Wang M; Gong M; Qiu F
    Biomed Chromatogr; 2016 Feb; 30(2):105-10. PubMed ID: 26031660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson's Disease Candidate, Using LC-MS/MS and LC-HRMS.
    Choi HI; Kim T; Kim JW; Lee GJ; Choi J; Chae YJ; Kim E; Koo TS
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Bioavailability Study of a Novel Smoothened Inhibitor TPB15 for Treatment of Triple-Negative Breast Cancer in Rats by High Performance Liquid Chromatography-Mass Spectrometry.
    Chen BY; Xu JH; Chen QQ; Wu HX; Ou BF; Zhou Z; Xu F; Wu SY; Xie SL; Wen DS
    Eur J Drug Metab Pharmacokinet; 2024 Sep; 49(5):645-655. PubMed ID: 39158678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, bioavailability and metabolism of neferine in rat by LC-MS/MS and LC-HRMS.
    Hu L; Wang Y; Shu C; Yu J; Chen Y; Li Y; Tao R; Yang H; Dou L
    Biomed Chromatogr; 2021 Nov; 35(11):e5193. PubMed ID: 34128252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
    Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
    J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Electro-Activated Dissociation Fragmentation Technique to Identifying Glucuronidation and Oxidative Metabolism Sites of Vepdegestrant by Liquid Chromatography-High Resolution Mass Spectrometry.
    He Y; Hou P; Long Z; Zheng Y; Tang C; Jones E; Diao X; Zhu M
    Drug Metab Dispos; 2024 Jun; 52(7):634-643. PubMed ID: 38830773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of motolimod concentration in rat plasma by liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
    Ji YG; Shin YM; Jeong JW; Choi HI; Lee SW; Lee JH; Lee KR; Koo TS
    J Pharm Biomed Anal; 2020 Feb; 179():112987. PubMed ID: 31761376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-ESI-MS/MS estimation of loratadine-loaded self-nanoemulsifying drug delivery systems in rat plasma: Pharmacokinetic evaluation and computer simulations by GastroPlus™.
    Verma S; Singh SK
    J Pharm Biomed Anal; 2016 May; 124():10-21. PubMed ID: 26922577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of PF-04620110, a novel inhibitor of diacylglycerol acyltransferase-1, in rat plasma using liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic studies.
    Lee KR; Choi SH; Song JS; Seo H; Chae YJ; Cho HE; Ahn JH; Ahn SH; Bae MA
    Biomed Chromatogr; 2013 Jul; 27(7):846-52. PubMed ID: 23420715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, bioavailability and metabolism of cligosiban, an antagonist of oxytocin receptor, in rat by liquid chromatography hyphenated with electrospray ionization tandem mass spectrometry.
    Yue X; Lu L; Liu H; Xue H
    J Pharm Biomed Anal; 2019 Feb; 164():725-733. PubMed ID: 30472591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a liquid chromatography-tandem mass spectrometry method for the assay of tafamidis in rat plasma: Application to a pharmacokinetic study in rats.
    Hyun HC; Jeong JW; Kim HR; Oh JH; Lee JH; Choi S; Kim YS; Koo TS
    J Pharm Biomed Anal; 2017 Apr; 137():90-95. PubMed ID: 28107689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of sacubitrilat and fimasartan in rat plasma by a triple quad liquid chromatography-tandem mass spectrometry method utilizing electrospray ionization in positive mode.
    Giri P; Joshi V; Giri S; Delvadia P; Jain MR
    Biomed Chromatogr; 2021 Feb; 35(2):e4981. PubMed ID: 32895916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of a astragaloside IV derivative LS-102 in plasma by ultra-performance liquid chromatography-tandem mass spectrometry in dog plasma and its application in a pharmacokinetic study.
    Sun WX; Zhang ZF; Xie J; He Y; Cheng Y; Ding LS; Luo P; Qing LS
    Phytomedicine; 2019 Feb; 53():243-251. PubMed ID: 30668404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability study of ginsenoside Rk1 in rat by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Li J; Zhang Y; Fan A; Li G; Liu Q
    Biomed Chromatogr; 2019 Sep; 33(9):e4580. PubMed ID: 31077415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.